{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:06:57Z","timestamp":1767474417336,"version":"3.48.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11321-5","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:30:14Z","timestamp":1767432614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting glioblastoma multiforme with Demethoxycurcumin and its analogues: current evidence and future directions"],"prefix":"10.1007","volume":"53","author":[{"given":"Yasamin","family":"Moeinipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Amadeh Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Alizadeh Shourab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Moeinipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Faridnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliasghar","family":"Moeinipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"2","key":"11321_CR1","first-page":"203","volume":"118","author":"V Kumar","year":"1994","unstructured":"Kumar V, Cotran RS (1994) Robbins\u2019 basic pathology. Arch Pathol Lab Med 118(2):203","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"11321_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2015.07.148","volume":"465","author":"J Wang","year":"2015","unstructured":"Wang J, Su H-k, Zhao H-f, Chen Z-p (2015) To S-sT. Progress in the application of molecular biomarkers in gliomas. Biochem Biophys Res Commun 465(1):1\u20134","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"11321_CR3","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.18632\/aging.103531","volume":"12","author":"L Shi","year":"2020","unstructured":"Shi L, Sun G, Zhu H (2020) Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK\/ERK signaling. Aging 12(14):14718","journal-title":"Aging"},{"issue":"12","key":"11321_CR4","first-page":"4915","volume":"30","author":"M Karsy","year":"2010","unstructured":"Karsy M, Albert L, Tobias ME, Murali R, Jhanwar-Uniyal M (2010) All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner. Anticancer Res 30(12):4915\u20134920","journal-title":"Anticancer Res"},{"issue":"11","key":"11321_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115503","volume":"22","author":"Y-P Huang","year":"2021","unstructured":"Huang Y-P, Ma Y-S, Kuo C-L, Liao C-L, Chen P-Y, Peng S-F et al (2021) Demethoxycurcumin suppresses human brain glioblastoma multiforme GBM 8401 cell xenograft tumor in nude mice in vivo. Int J Mol Sci 22(11):5503","journal-title":"Int J Mol Sci"},{"issue":"7","key":"11321_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","volume":"10","author":"W Wick","year":"2014","unstructured":"Wick W, Weller M, Van Den Bent M, Sanson M, Weiler M, Von Deimling A et al (2014) MGMT testing\u2014the challenges for biomarker-based glioma treatment. Nat Reviews Neurol 10(7):372\u2013385","journal-title":"Nat Reviews Neurol"},{"key":"11321_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3389\/fonc.2019.01547","volume":"9","author":"W Yu","year":"2020","unstructured":"Yu W, Zhang L, Wei Q, Shao A (2020) O6-methylguanine-DNA methyltransferase (MGMT): challenges and new opportunities in glioma chemotherapy. Front Oncol 9:1547","journal-title":"Front Oncol"},{"issue":"26","key":"11321_CR8","doi-asserted-by":"publisher","first-page":"25284","DOI":"10.1074\/jbc.M414645200","volume":"280","author":"J Fang","year":"2005","unstructured":"Fang J, Lu J, Holmgren A (2005) Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280(26):25284\u201325290","journal-title":"J Biol Chem"},{"key":"11321_CR9","unstructured":"Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research. Altern Med Rev. ;14(2)"},{"issue":"19","key":"11321_CR10","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1158\/1078-0432.CCR-05-0301","volume":"11","author":"MM LoTempio","year":"2005","unstructured":"LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN et al (2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11(19):6994\u20137002","journal-title":"Clin Cancer Res"},{"issue":"3","key":"11321_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","volume":"39","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39(3):283\u2013299","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"11321_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/antiox14030351","volume":"14","author":"A Nowacka","year":"2025","unstructured":"Nowacka A, Zi\u00f3\u0142kowska E, Smuczy\u0144ski W, Bo\u017ci\u0142ow D, \u015aniegocki M (2025) Potential of curcumin and its analogs in glioblastoma therapy. Antioxidants 14(3):351","journal-title":"Antioxidants"},{"issue":"2","key":"11321_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/biomedicines10020312","volume":"10","author":"V Zoi","year":"2022","unstructured":"Zoi V, Galani V, Tsekeris P, Kyritsis AP, Alexiou GA (2022) Radiosensitization and radioprotection by curcumin in glioblastoma and other cancers. Biomedicines 10(2):312","journal-title":"Biomedicines"},{"issue":"6","key":"11321_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"issue":"1","key":"11321_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/biof.1042","volume":"39","author":"M Metzler","year":"2013","unstructured":"Metzler M, Pfeiffer E, Schulz SI, Dempe JS (2013) Curcumin uptake and metabolism. Biofactors 39(1):14\u201320","journal-title":"Biofactors"},{"issue":"6","key":"11321_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/sj.bjp.0701914","volume":"124","author":"HW Chen","year":"1998","unstructured":"Chen HW, Huang HC (1998) Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 124(6):1029\u20131040","journal-title":"Br J Pharmacol"},{"issue":"5","key":"11321_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ijmm.2016.2524","volume":"37","author":"J Jankun","year":"2016","unstructured":"Jankun J, Wyganowska-\u015awi\u0105tkowska M, Dettlaff K, Jeli\u0144ska A, Surdacka A, W\u0105tr\u00f3bska-\u015awietlikowska D et al (2016) Determining whether Curcumin degradation\/condensation is actually bioactivation. Int J Mol Med 37(5):1151\u20131158","journal-title":"Int J Mol Med"},{"issue":"4","key":"11321_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1158\/1078-0432.CCR-06-1839","volume":"13","author":"C Tamvakopoulos","year":"2007","unstructured":"Tamvakopoulos C, Dimas K, Sofianos ZD, Hatziantoniou S, Han Z, Liu Z-L et al (2007) Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin Cancer Res 13(4):1269\u201377","journal-title":"Clin Cancer Res"},{"issue":"15","key":"11321_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O et al (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31(15):1869\u20131883","journal-title":"Oncogene"},{"key":"11321_CR20","doi-asserted-by":"crossref","unstructured":"Haldar AG, Dadure KM, Mahapatra DK (2021) Recent advancements of Curcumin analogs and Curcumin formulations in context to modern pharmacotherapeutics Perspectives. Applied pharmaceutical practice and nutraceuticals. Apple Academic, pp 121\u2013145","DOI":"10.1201\/9781003054894-9"},{"key":"11321_CR21","unstructured":"Information NCfB (2025) PubChem Compound Summary for CID 5469424, Demethoxycurcumin. National Center for Biotechnology Information"},{"key":"11321_CR22","unstructured":"Information NCfB (2025) PubChem compound summary for CID 5315472, bisdemethoxycurcumin. National Center for Biotechnology Information"},{"issue":"2","key":"11321_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1556\/AChrom.27.2015.2.13","volume":"27","author":"S Mollayi","year":"2015","unstructured":"Mollayi S, Tamhidi S, Hashempour H, Ghassempour A (2015) Recycling preparative high performance liquid chromatography for the separation of curcumin from curcuminoids in curcuma longa L. Acta Chromatogr 27(2):387\u2013398","journal-title":"Acta Chromatogr"},{"key":"11321_CR24","doi-asserted-by":"crossref","unstructured":"Desmarchelier C, Sus N, Marconot G, Gillet G, Resseguier N, Frank J (2023) Demethoxycurcumin and bisdemethoxycurcumin are more bioavailable than curcumin: A meta-analysis of randomized cross-over trials in healthy humans and an in vitro mechanistic exploration. Proceedings: MDPI; p. 94","DOI":"10.3390\/proceedings2023091094"},{"issue":"4","key":"11321_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bbrc.2009.04.149","volume":"384","author":"PM Luthra","year":"2009","unstructured":"Luthra PM, Kumar R, Prakash A (2009) Demethoxycurcumin induces Bcl-2 mediated G2\/M arrest and apoptosis in human glioma U87 cells. Biochem Biophys Res Commun 384(4):420\u2013425","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"11321_CR26","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3892\/or.2015.3865","volume":"33","author":"Y-C Ko","year":"2015","unstructured":"Ko Y-C, Lien J-C, Liu H-C, Hsu S-C, Ji B-C, Yang M-D et al (2015) Demethoxycurcumin induces the apoptosis of human lung cancer NCI-H460 cells through the mitochondrial-dependent pathway. Oncol Rep 33(5):2429\u201337","journal-title":"Oncol Rep"},{"issue":"1","key":"11321_CR27","first-page":"85","volume":"28","author":"X Ni","year":"2012","unstructured":"Ni X, Zhang A, Zhao Z, Shen Y, Wang S (2012) Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells. Oncol Rep 28(1):85\u201390","journal-title":"Oncol Rep"},{"issue":"26","key":"11321_CR28","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1021\/jf4012455","volume":"61","author":"J-M Shieh","year":"2013","unstructured":"Shieh J-M, Chen Y-C, Lin Y-C, Lin J-N, Chen W-C, Chen Y-Y et al (2013) Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. J Agric Food Chem 61(26):6366\u201375","journal-title":"J Agric Food Chem"},{"issue":"1","key":"11321_CR29","volume":"2012","author":"T-Y Huang","year":"2012","unstructured":"Huang T-Y, Hsu C-W, Chang W-C, Wang M-Y, Wu J-F, Hsu Y-C (2012) Demethoxycurcumin retards cell growth and induces apoptosis in human brain malignant glioma GBM 8401 cells. Evid Based Complement Alternat Med 2012(1):396573","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"11321_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.intimp.2011.12.009","volume":"12","author":"A Olivera","year":"2012","unstructured":"Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC et al (2012) Inhibition of the NF-\u03baB signaling pathway by the curcumin analog, 3, 5-Bis (2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol 12(2):368\u201377","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"11321_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mnfr.201100270","volume":"56","author":"JH Kim","year":"2012","unstructured":"Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB (2012) Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-\u03baB and NF\u2010\u03baB\u2010regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res 56(3):454\u2013465","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"11321_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","volume":"63","author":"JU Marquardt","year":"2015","unstructured":"Marquardt JU, Gomez-Quiroz L, Camacho LOA, Pinna F, Lee Y-H, Kitade M et al (2015) Curcumin effectively inhibits oncogenic NF-\u03baB signaling and restrains stemness features in liver cancer. J Hepatol 63(3):661\u20139","journal-title":"J Hepatol"},{"issue":"1","key":"11321_CR33","first-page":"11","volume":"4","author":"C-L Lin","year":"2008","unstructured":"Lin C-L, Lin J-K (2008) Curcumin: a potential cancer chemopreventive agent through suppressing NF-\u03baB signaling. J Cancer Mol 4(1):11\u201316","journal-title":"J Cancer Mol"},{"key":"11321_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.taap.2018.02.020","volume":"345","author":"R Kumar","year":"2018","unstructured":"Kumar R, Lal N, Nemaysh V, Luthra PM (2018) Demethoxycurcumin mediated targeting of MnSOD leading to activation of apoptotic pathway and inhibition of Akt\/NF-\u03baB survival signalling in human glioma U87 MG cells. Toxicol Appl Pharmacol 345:75\u201393","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"11321_CR35","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.21873\/anticanres.14952","volume":"41","author":"R-Y Su","year":"2021","unstructured":"Su R-Y, Hsueh S-C, Chen C-Y, Hsu M-J, Lu H-F, Peng S-F et al (2021) Demethoxycurcumin suppresses proliferation, migration, and invasion of human brain glioblastoma multiforme GBM 8401 cells via PI3K\/Akt pathway. Anticancer Res 41(4):1859\u201370","journal-title":"Anticancer Res"},{"key":"11321_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113528","volume":"221","author":"L Shi","year":"2021","unstructured":"Shi L, Gao L-l, Cai S-z, Xiong Q-w, Ma Z-r (2021) A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells. Eur J Med Chem 221:113528","journal-title":"Eur J Med Chem"},{"issue":"12","key":"11321_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23123217","volume":"23","author":"Y-Y Chen","year":"2018","unstructured":"Chen Y-Y, Lin Y-J, Huang W-T, Hung C-C, Lin H-Y, Tu Y-C et al (2018) Demethoxycurcumin-loaded chitosan nanoparticle downregulates DNA repair pathway to improve cisplatin-induced apoptosis in non-small cell lung cancer. Molecules 23(12):3217","journal-title":"Molecules"},{"issue":"5","key":"11321_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12072","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hong C, Chen X, Qin Z (2020) Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway. Oncol Lett 20(5):209","journal-title":"Oncol Lett"},{"key":"11321_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116470","volume":"174","author":"M Song","year":"2024","unstructured":"Song M, Wang T, Liu T, Lei T, Teng X, Peng Q et al (2024) DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment. Biomed Pharmacother 174:116470","journal-title":"Biomed Pharmacother"},{"key":"11321_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.phymed.2018.08.005","volume":"53","author":"C-Y Lin","year":"2019","unstructured":"Lin C-Y, Hung C-C, Wang CC, Lin H-Y, Huang S-H, Sheu M-J (2019) Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways. Phytomedicine 53:28\u201336","journal-title":"Phytomedicine"},{"issue":"5","key":"11321_CR41","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.21037\/tcr-21-2410","volume":"11","author":"G-J Lee","year":"2022","unstructured":"Lee G-J, Lim H, Seo J-Y, Kang K-R, Kim DK, You J-S et al (2022) Demethoxycurcumin induces apoptosis via inhibition of NF-\u03baB pathway in FaDu human head and neck squamous cell carcinoma. Transl Cancer Res 11(5):1064","journal-title":"Transl Cancer Res"},{"key":"11321_CR42","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.2147\/CMAR.S210076","volume":"11","author":"C Qian","year":"2019","unstructured":"Qian C, Wang B, Zou Y, Zhang Y, Hu X, Sun W et al (2019) MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to Demethoxycurcumin. Cancer Manag Res 11:6829\u20136840","journal-title":"Cancer Manag Res"},{"issue":"26","key":"11321_CR43","doi-asserted-by":"publisher","first-page":"43237","DOI":"10.18632\/oncotarget.18018","volume":"8","author":"L Chen","year":"2017","unstructured":"Chen L, Shi L, Wang W, Zhou Y (2017) ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin. Oncotarget 8(26):43237","journal-title":"Oncotarget"},{"issue":"23","key":"11321_CR44","doi-asserted-by":"publisher","first-page":"23795","DOI":"10.18632\/aging.103981","volume":"12","author":"L Shi","year":"2020","unstructured":"Shi L, Sun G, Zhang Y (2020) Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas. Aging 12(23):23795","journal-title":"Aging"},{"issue":"5","key":"11321_CR45","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.7150\/jca.65543","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Cheng Z, Shi L, Mao G (2022) miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein. J Cancer 13(5):1490","journal-title":"J Cancer"},{"issue":"3","key":"11321_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317694302","volume":"39","author":"Z Du","year":"2017","unstructured":"Du Z, Sha X (2017) Demethoxycurcumin inhibited human epithelia ovarian cancer cells\u2019 growth via up-regulating miR-551a. Tumor Biol 39(3):1010428317694302","journal-title":"Tumor Biol"},{"issue":"7","key":"11321_CR47","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1002\/jcb.26803","volume":"119","author":"L Shi","year":"2018","unstructured":"Shi L, Sun G (2018) DMC is not better than TMZ on intracranial anti-glioma effects. J Cell Biochem 119(7):6057\u20136064","journal-title":"J Cell Biochem"},{"issue":"1","key":"11321_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06355-z","volume":"23","author":"L Shi","year":"2025","unstructured":"Shi L, Fei X, Huang J, He B, Sun Z, Sun G (2025) DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33\/SLC25A1\/mitochondrial oxidative phosphorylation pathway. J Transl Med 23(1):363","journal-title":"J Transl Med"},{"key":"11321_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.756817","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Shi L, Wang Z (2021) A novel hydroxamic acid-based curcumin derivative as potent histone deacetylase inhibitor for the treatment of glioblastoma. Front Oncol 11:756817","journal-title":"Front Oncol"},{"issue":"6","key":"11321_CR50","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.18632\/aging.204610","volume":"15","author":"G Liu","year":"2023","unstructured":"Liu G, Chen J, Bao Z (2023) Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells. Aging 15(6):2221","journal-title":"Aging"},{"issue":"23","key":"11321_CR51","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1021\/jm020200g","volume":"45","author":"H Ohtsu","year":"2002","unstructured":"Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang H-K, Itokawa H et al (2002) Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 45(23):5037\u20135042","journal-title":"J Med Chem"},{"issue":"1","key":"11321_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jcp.25749","volume":"233","author":"M Teymouri","year":"2018","unstructured":"Teymouri M, Barati N, Pirro M, Sahebkar A (2018) Biological and pharmacological evaluation of dimethoxycurcumin: a metabolically stable curcumin analogue with a promising therapeutic potential. J Cell Physiol 233(1):124\u2013140","journal-title":"J Cell Physiol"},{"issue":"10","key":"11321_CR53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/15592294.2016.1226452","volume":"11","author":"HE Hassan","year":"2016","unstructured":"Hassan HE, Keita J-A, Narayan L, Brady SM, Frederick R, Carlson S et al (2016) The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effect. Epigenetics 11(10):740\u2013749","journal-title":"Epigenetics"},{"issue":"4","key":"11321_CR54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbagen.2007.11.016","volume":"1780","author":"A Kunwar","year":"2008","unstructured":"Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini K (2008) Quantitative cellular uptake, localization and cytotoxicity of Curcumin in normal and tumor cells. Biochim Et Biophys Acta (BBA)-General Subj 1780(4):673\u2013679","journal-title":"Biochim Et Biophys Acta (BBA)-General Subj"},{"issue":"8","key":"11321_CR55","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3109\/10715762.2011.571681","volume":"45","author":"A Kunwar","year":"2011","unstructured":"Kunwar A, Barik A, Sandur SK, Indira Priyadarsini K (2011) Differential antioxidant\/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of Curcumin. Free Radic Res 45(8):959\u2013965","journal-title":"Free Radic Res"},{"key":"11321_CR56","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.2147\/OTT.S313961","volume":"14","author":"S Luo","year":"2021","unstructured":"Luo S, Wu Y-P, Huang L, Huang S, Hueng D (2021) The anti-cancer effect of four Curcumin analogues on human glioma cells. Onco Targets Ther 14:4345\u20134359","journal-title":"Onco Targets Ther"},{"issue":"12","key":"11321_CR57","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4111\/kju.2010.51.12.870","volume":"51","author":"JW Lee","year":"2010","unstructured":"Lee JW, Hong HM, Kwon DD, Pae H-O, Jeong HJ (2010) Dimethoxycurcumin, a structural analogue of curcumin, induces apoptosis in human renal carcinoma Caki cells through the production of reactive oxygen species, the release of cytochrome C, and the activation of caspase-3. Korean J Urol 51(12):870\u2013878","journal-title":"Korean J Urol"},{"issue":"1","key":"11321_CR58","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbrc.2016.06.144","volume":"478","author":"S Jayakumar","year":"2016","unstructured":"Jayakumar S, Patwardhan R, Pal D, Sharma D, Sandur SK (2016) Dimethoxycurcumin, a metabolically stable analogue of Curcumin enhances the radiosensitivity of cancer cells: possible involvement of ROS and thioredoxin reductase. Biochem Biophys Res Commun 478(1):446\u2013454","journal-title":"Biochem Biophys Res Commun"},{"key":"11321_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcis.2021.03.086","volume":"594","author":"MA Tomeh","year":"2021","unstructured":"Tomeh MA, Hadianamrei R, Sun W, Xu D, Brown S, Zhao X (2021) Stiffness-tuneable nanocarriers for controlled delivery of ASC-J9 into colorectal cancer cells. J Colloid Interface Sci 594:513\u2013521","journal-title":"J Colloid Interface Sci"},{"issue":"5","key":"11321_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051942","volume":"26","author":"X Liu","year":"2025","unstructured":"Liu X, Su Y-X, Yang Y-M, Li R-T, Zhang Z-J (2025) The small molecules of plant origin with anti-glioma activity. Int J Mol Sci 26(5):1942","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11321_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3460001","volume":"346","author":"D Mustacich","year":"2000","unstructured":"Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346(1):1\u20138","journal-title":"Biochem J"},{"issue":"3","key":"11321_CR62","first-page":"2398","volume":"16","author":"L Hu","year":"2024","unstructured":"Hu L, Bao Z (2024) Inhibitory effect of a novel Curcumin derivative DMC-HA on keloid fibroblasts. Aging 16(3):2398","journal-title":"Aging"},{"issue":"24","key":"11321_CR63","doi-asserted-by":"publisher","first-page":"15183","DOI":"10.18632\/aging.205340","volume":"15","author":"L Shi","year":"2023","unstructured":"Shi L, Wang Z, Rong J, Fei X, Li X, He B et al (2023) Inhibition of TGF-\u03b21-induced epithelial-mesenchymal transition in gliomas by DMC-HA. Aging 15(24):15183","journal-title":"Aging"},{"issue":"1","key":"11321_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00432-019-03107-7","volume":"146","author":"M Mehner","year":"2020","unstructured":"Mehner M, Kubelt C, Adamski V, Schmitt C, Synowitz M, Held-Feindt J (2020) Combined treatment of AT101 and Demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol 146(1):117\u2013126","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"11321_CR65","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1007\/s13277-015-3427-x","volume":"36","author":"L Shi","year":"2015","unstructured":"Shi L, Fei X, Wang Z (2015) Demethoxycurcumin was prior to Temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells. Tumor Biol 36(9):7107\u20137119","journal-title":"Tumor Biol"},{"issue":"12","key":"11321_CR66","doi-asserted-by":"publisher","first-page":"15847","DOI":"10.1007\/s13277-016-5399-x","volume":"37","author":"L Leng","year":"2016","unstructured":"Leng L, Zhong X, Sun G, Qiu W, Shi L (2016) Demethoxycurcumin was superior to Temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo. Tumor Biol 37(12):15847\u201315857","journal-title":"Tumor Biol"},{"issue":"10","key":"11321_CR67","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/membranes13100841","volume":"13","author":"S Sokolov","year":"2023","unstructured":"Sokolov S, Zyrina A, Akimov S, Knorre D, Severin F (2023) Toxic effects of penetrating cations. Membranes 13(10):841","journal-title":"Membranes"},{"key":"11321_CR68","doi-asserted-by":"publisher","first-page":"101312","DOI":"10.1016\/j.tranon.2021.101312","volume":"16","author":"G Shanmugam","year":"2022","unstructured":"Shanmugam G, Rakshit S, Sarkar K (2022) HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases. Transl Oncol 16:101312","journal-title":"Transl Oncol"},{"issue":"16","key":"11321_CR69","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.18632\/oncotarget.2289","volume":"5","author":"M Kroesen","year":"2014","unstructured":"Kroesen M, Gielen P, Brok IC, Armandari I, Hoogerbrugge PM, Adema GJ (2014) HDAC inhibitors and immunotherapy; a double edged sword? Oncotarget 5(16):6558","journal-title":"Oncotarget"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11321-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:02:40Z","timestamp":1767474160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11321-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11321"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11321-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable for this review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"245"}}